Statistics for An open-label trial to assess the safety of regorafenib in turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)
Total visits
| views | |
|---|---|
| An open-label trial to assess the safety of regorafenib in turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD) | 3 |
Total visits per month
| views | |
|---|---|
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 3 |
| September 2024 | 0 |